Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells

PLoS Pathogens

Volumn 12, Issue 6, 2016, Pages

  Berneking, Laura ^a   Schnapp, Marie ^a   Rumm, Andreas ^a   Trasak, Claudia ^a   Ruckdeschel, Klaus ^a   Alawi, Malik ^a,b   Grundhoff, Adam ^b   Kikhney, Alexey G ^c   Koch Nolte, Friedrich ^a   Buck, Friedrich ^a   Perbandt, Markus ^a,d   Betzel, Christian ^d   Svergun, Dmitri I ^c   Hentschke, Moritz ^a   Aepfelbacher, Martin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DEAD BOX PROTEIN; EXPORTIN 1; INTERLEUKIN 10; S6 KINASE; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN M; DDX3X PROTEIN, HUMAN; OUTER MEMBRANE PROTEIN; RPS6KA1 PROTEIN, HUMAN; VIRULENCE FACTOR; YOPM PROTEIN, YERSINIA;

ARTICLE; CONFOCAL MICROSCOPY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MACROPHAGE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY; YERSINIA ENTEROCOLITICA; BIOSYNTHESIS; CELL LINE; CELL NUCLEUS; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HOST PARASITE INTERACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; YERSINIA INFECTION;

BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CRYSTALLOGRAPHY, X-RAY; DEAD-BOX RNA HELICASES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNOPRECIPITATION; MACROPHAGES; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; VIRULENCE FACTORS; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 84978852385     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005660     Document Type: Article

References (93)

1. Leung KY, Straley SC, The yopM gene of Yersinia pestis encodes a released protein having homology with the human platelet surface protein GPIb alpha. Journal of bacteriology. 1989;171(9):4623–32. 2670888
2. Boland A, Havaux S, Cornelis GR, Heterogeneity of the Yersinia YopM protein. Microbial pathogenesis. 1998;25(6):343–8. 9895273
3. Boland A, Sory MP, Iriarte M, Kerbourch C, Wattiau P, Cornelis GR, Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus. The EMBO journal. 1996;15(19):5191–201. 8895564
4. Uittenbogaard AM, Chelvarajan RL, Myers-Morales T, Gorman AA, Brickey WJ, Ye Z, et al. Toward a molecular pathogenic pathway for Yersinia pestis YopM. Frontiers in cellular and infection microbiology. 2012;2:155. doi: 10.3389/fcimb.2012.0015523248776
5. Galan JE, Wolf-Watz H, Protein delivery into eukaryotic cells by type III secretion machines. Nature. 2006;444(7119):567–73. 17136086
6. Trulzsch K, Sporleder T, Igwe EI, Russmann H, Heesemann J, Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infection and immunity. 2004;72(9):5227–34. 15322017
7. McCoy MW, Marre ML, Lesser CF, Mecsas J, The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infection and immunity. 2010;78(6):2584–98. doi: 10.1128/IAI.00141-1020368345
8. McPhee JB, Mena P, Bliska JB, Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infection and immunity. 2010;78(8):3529–39. doi: 10.1128/IAI.00269-1020515922
9. Benabdillah R, Mota LJ, Lutzelschwab S, Demoinet E, Cornelis GR, Identification of a nuclear targeting signal in YopM from Yersinia spp. Microbial pathogenesis. 2004;36(5):247–61. 15043860
10. Ruter C, Buss C, Scharnert J, Heusipp G, Schmidt MA, A newly identified bacterial cell-penetrating peptide that reduces the transcription of pro-inflammatory cytokines. Journal of cell science. 2010;123(Pt 13):2190–8. doi: 10.1242/jcs.06301620554895
11. Skrzypek E, Cowan C, Straley SC, Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Molecular microbiology. 1998;30(5):1051–65. 9988481
12. Skrzypek E, Myers-Morales T, Whiteheart SW, Straley SC, Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells. Infection and immunity. 2003;71(2):937–47. 12540576
13. Lesser CF, Miller SI, Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. The EMBO journal. 2001;20(8):1840–9. 11296218
14. Vieux EF, Barrick D, Deletion of internal structured repeats increases the stability of a leucine-rich repeat protein, YopM. Biophysical chemistry. 2011;159(1):152–61. doi: 10.1016/j.bpc.2011.06.00421764506
15. Scharnert J, Greune L, Zeuschner D, Lubos ML, Alexander Schmidt M, Ruter C, Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM. Cellular and molecular life sciences: CMLS. 2013;70(24):4809–23. doi: 10.1007/s00018-013-1413-223835836
16. Evdokimov AG, Anderson DE, Routzahn KM, Waugh DS, Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. Journal of molecular biology. 2001;312(4):807–21. 11575934
17. Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007;130(5):906–17. 17803912
18. Uff S, Clemetson JM, Harrison T, Clemetson KJ, Emsley J, Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation. The Journal of biological chemistry. 2002;277(38):35657–63. 12087105
19. McDonald C, Vacratsis PO, Bliska JB, Dixon JE, The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. The Journal of biological chemistry. 2003;278(20):18514–23. 12626518
20. Hentschke M, Berneking L, Belmar Campos C, Buck F, Ruckdeschel K, Aepfelbacher M, Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation. PloS one. 2010;5(10).
21. Anjum R, Blenis J, The RSK family of kinases: emerging roles in cellular signalling. Nature reviews Molecular cell biology. 2008;9(10):747–58. doi: 10.1038/nrm250918813292
22. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O, Plague bacteria target immune cells during infection. Science. 2005;309(5741):1739–41. 16051750
23. Ye Z, Kerschen EJ, Cohen DA, Kaplan AM, van Rooijen N, Straley SC, Gr1+ cells control growth of YopM-negative yersinia pestis during systemic plague. Infection and immunity. 2009;77(9):3791–806. doi: 10.1128/IAI.00284-0919581396
24. Ye Z, Uittenbogaard AM, Cohen DA, Kaplan AM, Ambati J, Straley SC, Distinct CCR2(+) Gr1(+) cells control growth of the Yersinia pestis DeltayopM mutant in liver and spleen during systemic plague. Infection and immunity. 2011;79(2):674–87. doi: 10.1128/IAI.00808-1021149593
25. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC, The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infection and immunity. 2004;72(8):4589–602. 15271919
26. Hofling S, Scharnert J, Cromme C, Bertrand J, Pap T, Schmidt MA, et al. Manipulation of pro-inflammatory cytokine production by the bacterial cell-penetrating effector protein YopM is independent of its interaction with host cell kinases RSK1 and PRK2. Virulence. 2014;5(7):761–71. doi: 10.4161/viru.2906225513777
27. LaRock CN, Cookson BT, The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell host & microbe. 2012;12(6):799–805.
28. Chung LK, Philip NH, Schmidt VA, Koller A, Strowig T, Flavell RA, et al. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. mBio. 2014;5(4):e01402–14. doi: 10.1128/mBio.01402-1424987096
29. McPhee JB, Mena P, Zhang Y, Bliska JB, Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM. Infection and immunity. 2012;80(7):2519–27. doi: 10.1128/IAI.06364-1122547545
30. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, Seraphin B, A generic protein purification method for protein complex characterization and proteome exploration. Nature biotechnology. 1999;17(10):1030–2. 10504710
31. Hogbom M, Collins R, van den Berg S, Jenvert RM, Karlberg T, Kotenyova T, et al. Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP. Journal of molecular biology. 2007;372(1):150–9. 17631897
32. Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S, Protein-binding assays in biological liquids using microscale thermophoresis. Nature communications. 2010;1:100. doi: 10.1038/ncomms109320981028
33. Mertens HD, Svergun DI, Structural characterization of proteins and complexes using small-angle X-ray solution scattering. Journal of structural biology. 2010;172(1):128–41. doi: 10.1016/j.jsb.2010.06.01220558299
34. Krissinel E, Henrick K, Inference of macromolecular assemblies from crystalline state. Journal of molecular biology. 2007;372(3):774–97. 17681537
35. Schroder M, Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochemical pharmacology. 2010;79(3):297–306. doi: 10.1016/j.bcp.2009.08.03219782656
36. Schroder M, Viruses and the human DEAD-box helicase DDX3: inhibition or exploitation?Biochemical Society transactions. 2011;39(2):679–83. doi: 10.1042/BST039067921428961
37. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT, Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell. 2004;119(3):381–92. 15507209
38. Blenis J, Signal transduction via the MAP kinases: proceed at your own RSK. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(13):5889–92. 8392180
39. Chen RH, Sarnecki C, Blenis J, Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Molecular and cellular biology. 1992;12(3):915–27. 1545823
40. Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P, Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. The Journal of biological chemistry. 1998;273(3):1496–505. 9430688
41. Hoffmann R, van Erp K, Trulzsch K, Heesemann J, Transcriptional responses of murine macrophages to infection with Yersinia enterocolitica. Cellular microbiology. 2004;6(4):377–90. 15009029
42. Sauvonnet N, Pradet-Balade B, Garcia-Sanz JA, Cornelis GR, Regulation of mRNA expression in macrophages after Yersinia enterocolitica infection. Role of different Yop effectors. The Journal of biological chemistry. 2002;277(28):25133–42. 12006597
43. Heesemann J, Laufs R, Construction of a mobilizable Yersinia enterocolitica virulence plasmid. Journal of bacteriology. 1983;155(2):761–7. 6874644
44. Trulzsch K, Roggenkamp A, Aepfelbacher M, Wilharm G, Ruckdeschel K, Heesemann J, Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica. International journal of medical microbiology: IJMM. 2003;293(2–3):167–77. 12868653
45. Bleichert F, Baserga SJ, The long unwinding road of RNA helicases. Molecular cell. 2007;27(3):339–52. 17679086
46. Jankowsky E, RNA helicases at work: binding and rearranging. Trends in biochemical sciences. 2011;36(1):19–29. doi: 10.1016/j.tibs.2010.07.00820813532
47. Kim YS, Lee SG, Park SH, Song K, Gene structure of the human DDX3 and chromosome mapping of its related sequences. Molecules and cells. 2001;12(2):209–14. 11710523
48. Schroder M, Baran M, Bowie AG, Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. The EMBO journal. 2008;27(15):2147–57. doi: 10.1038/emboj.2008.14318636090
49. Chen HH, Yu HI, Cho WC, Tarn WY, DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway. Oncogene. 2015;34(21):2790–800. doi: 10.1038/onc.2014.19025043297
50. Porcheray F, Miklos DB, Floyd BH, Sarantopoulos S, Bellucci R, Soiffer RJ, et al. Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation. Transplantation. 2011;92(3):359–65. doi: 10.1097/TP.0b013e3182244cc321709606
51. Jiang L, Gu ZH, Yan ZX, Zhao X, Xie YY, Zhang ZG, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. Nat Genet. 2015;47(9):1061–6.
52. Hines J, Skrzypek E, Kajava AV, Straley SC, Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins. Microbial pathogenesis. 2001;30(4):193–209. 11312613
53. Skrzypek E, Straley SC, Interaction between Yersinia pestis YopM protein and human alpha-thrombin. Thrombosis research. 1996;84(1):33–43. 8885145
54. Leung KY, Reisner BS, Straley SC, YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infection and immunity. 1990;58(10):3262–71. 2401564
55. Heusipp G, Spekker K, Brast S, Falker S, Schmidt MA, YopM of Yersinia enterocolitica specifically interacts with alpha1-antitrypsin without affecting the anti-protease activity. Microbiology. 2006;152(Pt 5):1327–35. 16622050
56. Schroder K, Tschopp J, The inflammasomes. Cell. 2010;140(6):821–32. doi: 10.1016/j.cell.2010.01.04020303873
57. Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, et al. Birth of the D-E-A-D box. Nature. 1989;337(6203):121–2. 2563148
58. Cordin O, Banroques J, Tanner NK, Linder P, The DEAD-box protein family of RNA helicases. Gene. 2006;367:17–37. 16337753
59. Cargnello M, Roux PP, Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and molecular biology reviews: MMBR. 2011;75(1):50–83. doi: 10.1128/MMBR.00031-1021372320
60. Carriere A, Ray H, Blenis J, Roux PP, The RSK factors of activating the Ras/MAPK signaling cascade. Frontiers in bioscience: a journal and virtual library. 2008;13:4258–75.
61. Yoon S, Seger R, The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth factors. 2006;24(1):21–44. 16393692
62. Richards SA, Dreisbach VC, Murphy LO, Blenis J, Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1. Molecular and cellular biology. 2001;21(21):7470–80. 11585927
63. Ghoda L, Lin X, Greene WC, The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro. The Journal of biological chemistry. 1997;272(34):21281–8. 9261139
64. Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, Lannigan DA, pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Molecular and cellular biology. 1998;18(4):1978–84. 9528769
65. Schouten GJ, Vertegaal AC, Whiteside ST, Israel A, Toebes M, Dorsman JC, et al. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. The EMBO journal. 1997;16(11):3133–44. 9214631
66. Xing J, Ginty DD, Greenberg ME, Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 1996;273(5277):959–63. 8688081
67. Sory MP, Boland A, Lambermont I, Cornelis GR, Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(26):11998–2002. 8618831
68. Takahashi M, Mukai H, Toshimori M, Miyamoto M, Ono Y, Proteolytic activation of PKN by caspase-3 or related protease during apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(20):11566–71. 9751706
69. Dettori R, Sonzogni S, Meyer L, Lopez-Garcia LA, Morrice NA, Zeuzem S, et al. Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1). The Journal of biological chemistry. 2009;284(44):30318–27. doi: 10.1074/jbc.M109.05115119723632
70. Heesemann J, Gross U, Schmidt N, Laufs R, Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infection and immunity. 1986;54(2):561–7. 3770952
71. Jacobi CA, Roggenkamp A, Rakin A, Zumbihl R, Leitritz L, Heesemann J, In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Molecular microbiology. 1998;30(4):865–82. 10094634
72. Koch-Nolte F, Glowacki G, Bannas P, Braasch F, Dubberke G, Ortolan E, et al. Use of genetic immunization to raise antibodies recognizing toxin-related cell surface ADP-ribosyltransferases in native conformation. Cellular immunology. 2005;236(1–2):66–71. 16271711
73. Kopp P, Lammers R, Aepfelbacher M, Woehlke G, Rudel T, Machuy N, et al. The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages. Molecular biology of the cell. 2006;17(6):2811–23. 16554367
74. Graham FL, van der Eb AJ, A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52(2):456–67. 4705382
75. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi: 10.1093/bioinformatics/bts63523104886
76. Liao Y, Smyth GK, Shi W, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–30. doi: 10.1093/bioinformatics/btt65624227677
77. Love MI, Huber W, Anders S, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology. 2014;15(12):550. 25516281
78. Jerabek-Willemsen M, Wienken CJ, Braun D, Baaske P, Duhr S, Molecular interaction studies using microscale thermophoresis. Assay and drug development technologies. 2011;9(4):342–53. doi: 10.1089/adt.2011.038021812660
79. Battye TG, Kontogiannis L, Johnson O, Powell HR, Leslie AG, iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta crystallographica Section D, Biological crystallography. 2011;67(Pt 4):271–81.
80. Evans P, Scaling and assessment of data quality. Acta crystallographica Section D, Biological crystallography. 2006;62(Pt 1):72–82. 16369096
81. Vagin A, Teplyakov A, Molecular replacement with MOLREP. Acta crystallographica Section D, Biological crystallography. 2010;66(Pt 1):22–5.
82. Murshudov GN, Vagin AA, Lebedev A, Wilson KS, Dodson EJ, Efficient anisotropic refinement of macromolecular structures using FFT. Acta crystallographica Section D, Biological crystallography. 1999;55(Pt 1):247–55. 10089417
83. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, et al. Overview of the CCP4 suite and current developments. Acta crystallographica Section D, Biological crystallography. 2011;67(Pt 4):235–42.
84. Brunger AT, Assessment of phase accuracy by cross validation: the free R value. Methods and applications. Acta crystallographica Section D, Biological crystallography. 1993;49(Pt 1):24–36. 15299543
85. Emsley P, Lohkamp B, Scott WG, Cowtan K, Features and development of Coot. Acta crystallographica Section D, Biological crystallography. 2010;66(Pt 4):486–501.
86. Laskowski RA, MacArthur M.W., Moss D.S., Thornten J.M, PROCHECK: a program to check the stereochemical quality of protein structures. Journal of applied crystallography. 1993;26:283–91.
87. Blanchet CE, Spilotros A, Schwemmer F, Graewert MA, Kikhney A, Jeffries CM, et al. Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY). Journal of applied crystallography. 2015;48(Pt 2):431–43.
88. Franke D, Kikhney AG, Svergun DI, Automated acquisition and analysis of small angle X-ray scattering data. Nuc Inst Meth A. 2012;689:52–9.
89. Svergun DI, Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J Appl Crystallogr. 1992;25:495–503.
90. Roy A, Kucukural A, Zhang Y, I-TASSER: a unified platform for automated protein structure and function prediction. Nature protocols. 2010;5(4):725–38.
91. Petoukhov MV, Svergun DI, Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophysical journal. 2005;89(2):1237–50. 15923225
92. Svergun DI, Barberato C, Koch MHJ, CRYSOL—a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates. J Appl Crystallogr. 1995;28:768–73.
93. Valentini E, Kikhney AG, Previtali G, Jeffries CM, Svergun DI, SASBDB, a repository for biological small-angle scattering data. Nucleic acids research. 2015;43(Database issue):D357–63. doi: 10.1093/nar/gku104725352555